Calton & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-774
Closed -$202K 356
2022
Q1
$202K Sell
774
-414
-35% -$108K 0.06% 330
2021
Q4
$260K Buy
1,188
+13
+1% +$2.85K 0.07% 296
2021
Q3
$213K Buy
+1,175
New +$213K 0.05% 365
2018
Q1
Sell
-229
Closed -$38K 1253
2017
Q4
$38K Buy
+229
New +$38K 0.01% 749